Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toos Daemen

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced CancersFenne L Komdeur, Amrita Singh, Stephanie van de Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I E van Poelgeest, Marij J P Welters, Renee Vermeij, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced CancersFenne L Komdeur, Amrita Singh, Stephanie van de Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I E van Poelgeest, Marij J P Welters, Renee Vermeij, et al.
Pageof 9